RECORD // Company

Vyome Holdings, Inc

Formerly: ReShape Lifesciences Inc.; OBALON THERAPEUTICS INC

Built 2026-11-22T01:20:26Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Records under a former name (4)

The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.

Matched by name only, not merged (1)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • ReShape Lifesciences · Ctgov · name equals 'Reshape Lifesciences' but other unrelated entities share it Possible match based on name, not a shared identifier. Compare the records. Compare

4 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-12 · accession 0001213900-26-118943

ItemValuePeriodFormFiledAccessionReport
Revenue$57,9983 months ended 2026-09-3010-Q2026-11-120001213900-26-1189432026-11-22 01:20 UTCReport an error
Net income (loss)$-885,4083 months ended 2026-09-3010-Q2026-11-120001213900-26-1189432026-11-22 01:20 UTCReport an error
Interest expense$2,9353 months ended 2026-09-3010-Q2026-11-120001213900-26-1189432026-11-22 01:20 UTCReport an error
Cash and cash equivalents$6,956,822at 2026-09-3010-Q2026-11-120001213900-26-1189432026-11-22 01:20 UTCReport an error

Negative as reported in the filing.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001427570
Ticker
HIND
Record ID
sx:sec:0001427570

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

20 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-12SEC EDGAR company profile2026-11-22 01:20 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-12SEC EDGAR company profile2026-11-22 01:20 UTCReport an error
State of incorporationDE2026-11-12SEC EDGAR company profile2026-11-22 01:20 UTCReport an error
Fiscal year end (MMDD)12312026-11-12SEC EDGAR company profile2026-11-22 01:20 UTCReport an error
Business address1001 CALLE AMANECER, SAN CLEMENTE, CA, 926732026-11-12SEC EDGAR company profile2026-11-22 01:20 UTCReport an error
ExchangesNasdaq2026-11-12SEC EDGAR company profile2026-11-22 01:20 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$319,7142025-12-3110-K, XBRL Revenues2026-11-22 01:20 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-10,262,0072025-12-3110-K, XBRL NetIncomeLoss2026-11-22 01:20 UTCReport an error
Total assets (at 2025-12-31)$6,497,1772025-12-3110-K, XBRL Assets2026-11-22 01:20 UTCReport an error
Stockholders' equity (at 2025-12-31)$3,762,0172025-12-3110-K, XBRL StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest2026-11-22 01:20 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$4,982,3332025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 01:20 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-3,748,8532025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 01:20 UTCReport an error
Operating lease liabilities (at 2026-12-31)$31,2582026-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 01:20 UTCReport an error
Form D total offering amount (D filed 2018-08-29)$10,000,0002018-08-29D2026-11-22 01:20 UTCReport an error
Form D total amount sold (D filed 2018-08-29)$10,000,0002018-08-29D2026-11-22 01:20 UTCReport an error
Form D industry groupBiotechnology2018-08-29D2026-11-22 01:20 UTCReport an error
Form D revenue rangeDecline to Disclose2018-08-29D2026-11-22 01:20 UTCReport an error
Form D date of first sale2018-08-232018-08-29D2026-11-22 01:20 UTCReport an error
8-K Item 5.02, Departure of Directors or Certain (filed 2026-08-28)Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 27, 2026, the board of directors (the “Board”) of Vyome Holdings, Inc. (the “Company”) appointed Jerry Leonard as the Company’s Chief Financial Officer. In connection with Mr. Leonard’s appointment, the Board, upon the recommendation of the compensation committee of the Board, approved a Consulting Agreement (the “CFO Agreement”) with ClearbridgeCFO, LLC, a Georgia limited liability company (“ClearBridge”), and Mr. Leonard, pursuant to which ClearBridge will assign Mr. Leonard to provide services as the Company’s Chief Financial Officer, effective as of September 1…2026-08-28SEC EDGAR 8-K 0001213900-26-095093 (text as filed, excerpt)2026-11-22 01:20 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-25)On August 25, 2026, Vyome Holdings, Inc. issued a press release announcing its financial results for its second fiscal quarter ended June 30, 2026. The full text of the press release is furnished herewith as Exhibit 99.1. The information disclosed under this Item 2.02, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act except as expressly set forth in such filing.2026-08-25SEC EDGAR 8-K 0001213900-26-093512 (text as filed, excerpt)2026-11-22 01:20 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.